title: Prevalence of 9-Valent Human Papillomavirus Types by Race/Ethnicity in the Prevaccine Era, United States, 2003-2006.
abstract: Before any vaccine introduction, overall DNA prevalence of any 9-valent human papillomavirus (9vHPV) types, HPV 31/33/45/52/58, and HPV 16/18 was 16.0%, 9.5%, and 6.2%, respectively, among female participants in National Health and Nutrition Examination Survey. Non-Hispanic black females were more likely to have infection with HPV 31/33/45/52/58, but not HPV 16/18, compared to non-Hispanic white females.
authors.affiliation: From the Centers for Disease Control and Prevention, Atlanta, GA.
authors.forename: Gui
authors.initials: G
authors.lastname: Liu
authors.forename: Elizabeth R
authors.initials: ER
authors.lastname: Unger
authors.forename: Susan
authors.initials: S
authors.lastname: Hariri
authors.forename: Martin
authors.initials: M
authors.lastname: Steinau
authors.forename: Lauri E
authors.initials: LE
authors.lastname: Markowitz
mesh_terms: D000293:Adolescent; D000328:Adult; D003367:Cotinine / Q000097:blood; D005006:Ethnicity; D005260:Female; D052162:Human papillomavirus 16 / Q000145:classification / Q000235:genetics / Q000276:immunology; D052161:Human papillomavirus 18 / Q000145:classification / Q000235:genetics / Q000276:immunology; D006801:Humans; D008875:Middle Aged; D009749:Nutrition Surveys; D027383:Papillomaviridae / Q000145:classification / Q000235:genetics / Q000276:immunology*; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000208:ethnology / Q000821:virology; D053918:Papillomavirus Vaccines / Q000276:immunology*; D015995:Prevalence; D057566:Self Report; D012747:Sexual Partners; D055815:Young Adult
chemical_list: D053918:Papillomavirus Vaccines; D003367:Cotinine